Riskpilot← Back to searchSign inGet full accessOxyr AB
ABActiveOrg 5566610076Dental practice care activities · NACE 8623Est. 20041-4 employees
Revenue 2025
SEK 0
EBITDA margin
—
-661% vs 2024
Equity ratio
97.0%
Financial strength
Net profit 2025
SEK 6,1M
+157% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -88K | -661% |
| Net profit | SEK 6,1M | +157% |
| Total assets | SEK 37,3M | +22% |
| Equity | SEK 36,1M | +21% |
| Employees | — | — |
Legal name
Oxyr AB
Org number
5566610076
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
22 april 2004
Share capital
SEK 100 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva tandläkarpraktik, värdepappershandel, fastighetshandel samt därmed förenlig verksamhet.
Address
Email
ekdahlarna@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −62 |
| EBITDA | −11 | −12 | −13 | −12 | −88 |
| Depreciation & amort. | −0 | — | — | — | −21 |
| EBIT | −11 | −12 | −13 | −12 | −110 |
| Net financials | 21 | 20 | 32 | 27 | 3 028 |
| Profit before tax | 2 509 | 2 608 | 3 518 | 3 016 | 6 966 |
| Tax | −537 | −538 | −725 | −621 | −817 |
| Net profit | 1 972 | 2 070 | 2 794 | 2 394 | 6 149 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 26 079 | 26 726 | 28 788 | 30 439 | 37 257 |
| Equity | 25 423 | 26 263 | 28 307 | 29 976 | 36 126 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 656 | 462 | 481 | 462 | 989 |
| Total debt | 656 | 462 | 481 | 462 | 989 |
EBITDA margin
-8843900.0%
This company
15.8%
Market median
-55974151% vs market
20212025
Equity ratio
97.0%
This company
38.2%
Market median
+154% vs market
20212025
Return on equity
17.0%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
614916500.0%
This company
8.1%
Market median
+7591561628% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oxyr AB 
Tegner Tandläkarna ABBoard members of Oxyr AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ivan Mikael Larsson | Audit | 0 companies |
| Anna Karolina Bertilsdotter Ekdahl | Board of Directors | 0 companies |
| Lars Åke Lennart Ekdahl | Deputy Board Member | 0 companies |